SCINAI IMMUNOTHERAPEUTICS LTD. Adjustments For Reconcile Profit Loss
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Adjustments For Reconcile Profit Loss of ILS 6.22 million for the 3-month period ending 2022-06-30, per its 6-K/A filed 2022-08-29.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForReconcileProfitLoss · last filed 2022-08-29
- SCINAI IMMUNOTHERAPEUTICS LTD. adjustments for reconcile profit loss for the quarter ending 2022-06-30 was 6.22M ILS, a 10.98% increase year-over-year.
- SCINAI IMMUNOTHERAPEUTICS LTD. adjustments for reconcile profit loss for the quarter ending 2021-12-31 was 3.01M ILS, a 10.47% increase year-over-year.
- SCINAI IMMUNOTHERAPEUTICS LTD. adjustments for reconcile profit loss for the quarter ending 2021-09-30 was 1.58M ILS.
- SCINAI IMMUNOTHERAPEUTICS LTD. adjustments for reconcile profit loss for the quarter ending 2021-06-30 was 5.60M ILS, a 81.00% decline year-over-year.
ILS
| Period end | Adjustments For Reconcile Profit Loss 3 month | Adjustments For Reconcile Profit Loss 6 month | Adjustments For Reconcile Profit Loss 9 month | Adjustments For Reconcile Profit Loss 12 month |
|---|---|---|---|---|
| 2022-06-30 | 6.22M ILS 6-K/A · filed 2022-08-29 | 9.58M ILS 6-K/A · filed 2022-08-29 | ||
| 2021-12-31 | 3.01M ILS derived: 6-K/A 12 month − 6-K/A 9 month · filed 2022-08-29 | 4.58M ILS derived: sum of 2 quarters · filed 2022-08-29 | 10.18M ILS derived: sum of 3 quarters · filed 2022-08-29 | 13.18M ILS 6-K/A · filed 2022-08-29 |
| 2021-09-30 | 1.58M ILS 6-K/A · filed 2021-12-27 | 7.18M ILS derived: sum of 2 quarters · filed 2022-08-29 | 10.17M ILS 6-K/A · filed 2021-12-27 | |
| 2021-06-30 | 5.60M ILS 6-K/A · filed 2022-08-29 | 8.60M ILS 6-K/A · filed 2022-08-29 | ||
| 2020-12-31 | 2.72M ILS derived: 20-F 12 month − 6-K/A 9 month · filed 2022-03-28 | -67.25M ILS derived: sum of 2 quarters · filed 2022-03-28 | -37.77M ILS derived: sum of 3 quarters · filed 2022-03-28 | -53.48M ILS 20-F · filed 2022-03-28 |
| 2020-09-30 | -69.97M ILS 6-K/A · filed 2021-12-27 | -40.49M ILS derived: sum of 2 quarters · filed 2021-12-27 | -56.20M ILS 6-K/A · filed 2021-12-27 | |
| 2020-06-30 | 29.48M ILS 6-K · filed 2020-10-02 | 13.77M ILS 6-K · filed 2020-10-02 | ||
| 2019-12-31 | 8.85M ILS derived: 20-F 12 month − 6-K 9 month · filed 2022-03-28 | 10.87M ILS derived: sum of 2 quarters · filed 2022-03-28 | 43.05M ILS derived: sum of 3 quarters · filed 2022-03-28 | 35.49M ILS 20-F · filed 2022-03-28 |
| 2019-09-30 | 2.02M ILS 6-K · filed 2021-01-28 | 34.20M ILS derived: sum of 2 quarters · filed 2021-01-28 | 26.64M ILS 6-K · filed 2021-01-28 | |
| 2019-06-30 | 32.18M ILS 6-K · filed 2020-10-02 | 24.62M ILS 6-K · filed 2020-10-02 | ||
| 2018-12-31 | 12.61M ILS 20-F · filed 2021-05-13 | |||
| 2017-12-31 | 22.16M ILS 20-F · filed 2020-06-12 | |||
| 2016-12-31 | -827.00K ILS 20-F · filed 2019-04-30 | |||
| 2015-12-31 | 276.00K ILS 20-F · filed 2018-04-30 |
USD
| Period end | Adjustments For Reconcile Profit Loss 3 month | Adjustments For Reconcile Profit Loss 6 month | Adjustments For Reconcile Profit Loss 9 month | Adjustments For Reconcile Profit Loss 12 month |
|---|---|---|---|---|
| 2022-06-30 | $2.74M 6-K/A · filed 2022-08-29 | |||
| 2021-12-31 | $1.09M derived: 20-F 12 month − 6-K/A 9 month · filed 2022-03-28 | $4.24M 20-F · filed 2022-03-28 | ||
| 2021-09-30 | $3.15M 6-K/A · filed 2021-12-27 | |||
| 2020-12-31 | -$16.63M 20-F · filed 2021-05-13 | |||
| 2017-12-31 | $6.39M 20-F · filed 2018-04-30 |